NEW YORK (GenomeWeb) – Sequenom reported after the close of the market Wednesday that its second quarter revenues fell 18 percent year over year on lower diagnostic services revenue.

The San Diego-based molecular diagnostics firm reported revenues of $32.8 million for the three months ended June 30, down from $39.8 million for the second quarter of 2014. It fell short of the average Wall Street estimate of $36.1 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

CNBC reports that Amazon invested in the startup Grail as it sees an opportunity for its cloud computing company in genomics.

Lawrence Krauss writes at Slate that science is needed for good public policy and should not be ignored.

Researchers are working on re-making the yeast genome from scratch, according to the Associated Press.

In Cell this week: functional profiling of Plasmodium genome, a self-inactivating rabies virus, and more.

Sponsored by

This webinar will address improvements in the library prep workflow for small RNA sequencing in serum and plasma.

Sponsored by

This webinar will demonstrate a new approach that combines precise FFPE tumor isolation with extraction-free DNA/RNA library preparation to minimize material losses and reduce the amount of tissue input required for NGS analysis.